Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients

Citation
S. Hoshii et al., Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients, PED NEPHROL, 14(4), 2000, pp. 275-279
Citations number
13
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Pediatrics
Journal title
PEDIATRIC NEPHROLOGY
ISSN journal
0931-041X → ACNP
Volume
14
Issue
4
Year of publication
2000
Pages
275 - 279
Database
ISI
SICI code
0931-041X(200004)14:4<275:SEPIPP>2.0.ZU;2-N
Abstract
The aim of this study was to define the incidence and characteristics of sc lerosing encapsulating peritonitis (SEP) in pediatric peritoneal dialysis ( PD) patients in Japan. A questionnaire was sent to all dialysis units with at least two pediatric PD patients. Among 687 patients registered, 11 cases (1.6%) of SEP were diagnosed. The mean age of patients with SEP at the sta rt of PD was 9.7+/-3.6 years and at SEP diagnosis, 19.1+/-3.8 years. All pa tients had undergone PD for more than 5 years, and the mean PD duration was 9.6+/-3.3 years. SEP was diagnosed in 6.6% and 12% of patients dialyzed fo r >5 years and >8 years, respectively. The incidence of peritonitis among p atients with SEP was not different from that among the Japanese pediatric r egistry. All patients had virtually no residual urine volume and 9 had impa ired peritoneal ultrafiltration. Peritoneal calcification was the most-freq uent radiological finding. Peritoneal biopsy was performed in 7 patients an d confirmed sclerotic peritonitis in all. Ten patients transferred to hemod ialysis, and only 1 patient underwent surgery. Three patients died. We reco mmend that patients on PD for more than 5 years who have impaired peritonea l ultrafiltration or peritoneal calcification should be carefully managed a s presumptive cases of SEP.